Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 691–705 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5723 SMN1 Gene (Spinal Muscular Atrophy Type 2) Genetic Test This genetic test analyzes the SMN1 gene to detect mutations associated with Spinal Muscular Atrophy Type 2.	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene deletions", "SMN1 gene point mutations", "SMN1 gene copy number variations"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Suspected Spinal Muscular Atrophy Type 2", "Family history of SMA", "Genetic counselling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21647-7 ICD-10: G12.1 Clinical summary This genetic test analyzes the SMN1 gene to detect mutations associated with Spinal Muscular Atrophy Type 2.
TEST-5828 SMN1 Gene Sequencing (SMA Type 3) Test This diagnostic test evaluates the SMN1 gene for deletions, duplications, and point mutations associated with Spinal Muscular Atrophy Type 3.	Whole Blood (Peripheral) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene copy number variations (exon 7/8 deletions/duplications)", "SMN1 gene point mutations", "SMN2 modifier copy number"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of Spinal Muscular Atrophy Type 3", "Family history of SMA", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81378-8 ICD-10: G12.1 Clinical summary This diagnostic test evaluates the SMN1 gene for deletions, duplications, and point mutations associated with Spinal Muscular Atrophy Type 3.
TEST-5727 SMN1 Gene Sequencing (Spinal Muscular Atrophy Type 4) Genetic Test This test evaluates the SMN1 gene for mutations associated with Spinal Muscular Atrophy Type 4.	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene sequence", "Point mutations", "Copy Number Variations (CNVs)", "Deep intronic variants"] Parameters [] Preparation ["Pre-genetic counselling session required", "Inform team of anticoagulant or immunosuppressant medications"] Indications ["Suspected clinical diagnosis of SMA Type 4", "Differentiation from other motor neuron diseases", "Reproductive planning for carriers"] Measurement technique Confirm with laboratory Codes LOINC: 78296-5 ICD-10: G12.1, Z14.8, Z13.79 Clinical summary This test evaluates the SMN1 gene for mutations associated with Spinal Muscular Atrophy Type 4.
TEST-5824 SMN1 Gene Sequencing for Spinal Muscular Atrophy Type 1 (NGS) Test This test evaluates the SMN1 gene for deletions, copy number variations, and point mutations associated with Spinal Muscular Atrophy Type 1.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene sequence", "SMN1 copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute febrile illness or within two weeks of a blood transfusion"] Indications ["Suspected Spinal Muscular Atrophy Type 1", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48086-0 ICD-10: G12.0, Z15.89, Z82.79 Clinical summary This test evaluates the SMN1 gene for deletions, copy number variations, and point mutations associated with Spinal Muscular Atrophy Type 1.
TEST-5915 SMPD1 Gene Niemann-Pick Disease Type A/B Genetic Test This test identifies pathogenic variants in the SMPD1 gene, confirming or ruling out Niemann-Pick disease types A and B.	Whole Blood (EDTA), Dried Blood Spot (FTA card), or Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMPD1 gene", "Point mutations", "Insertions", "Deletions", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Niemann-Pick disease type A or B", "Family history of Niemann-Pick disease", "Need for definitive molecular diagnosis", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81418-7 ICD-10: E75.24 Clinical summary This test identifies pathogenic variants in the SMPD1 gene, confirming or ruling out Niemann-Pick disease types A and B.
TEST-4652 SNAI2 Gene Piebaldism Test This test identifies pathogenic variants in the SNAI2 gene associated with Piebaldism.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNAI2 gene"] Parameters [] Preparation [] Indications ["Suspected Piebaldism", "Differential diagnosis of pigmentary disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81263-1 ICD-10: Q82.8 Clinical summary This test identifies pathogenic variants in the SNAI2 gene associated with Piebaldism.
TEST-6024 SOD2 Genetic Susceptibility Test for Diabetic Microvascular Complications (NGS) This test evaluates the SOD2 rs4880 polymorphism to assess genetic susceptibility to diabetic microvascular complications.	Whole blood (EDTA), Extracted DNA (≥1 µg), or Dried blood spot on FTA® Card	3 – 4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOD2 rs4880 (Val16Ala) polymorphism", "Genetic risk for diabetic microvascular complications"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with diabetes seeking risk stratification for microvascular complications", "Patients with family history of severe diabetic complications"] Measurement technique Confirm with laboratory Codes LOINC: 21683-1 ICD-10: Z15.89 Clinical summary This test evaluates the SOD2 rs4880 polymorphism to assess genetic susceptibility to diabetic microvascular complications.
TEST-1113 Solid Tumor Combo1 Panel: EGFR, ALK, ROS1, MET, PD-L1 Genetic Profiling Test This test evaluates key genetic alterations and protein expression levels in solid tumor tissue to guide targeted cancer therapy and immunotherapy selection.	Archival Tissue Specimen (FFPE block)	5–7 working days	5,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "ALK fusions", "ROS1 fusions", "MET amplification", "PD-L1 expression"] Parameters [] Preparation [] Indications ["Diagnosis of non-small cell lung cancer", "Diagnosis of other solid malignancies", "Guidance for targeted therapy selection", "Guidance for immunotherapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 91813-9 ICD-10: C34.9 Clinical summary This test evaluates key genetic alterations and protein expression levels in solid tumor tissue to guide targeted cancer therapy and immunotherapy selection.
TEST-1104 Solid Tumor Combo2 Panel (MSI, NRAS, KRAS, BRAF, HRAS) Test This diagnostic test evaluates microsatellite instability (MSI) status and specific mutations (NRAS, KRAS, BRAF, HRAS) in solid tumor tissue.	Tissue Biopsy (FFPE or fresh)	10 calendar days	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Microsatellite Instability (MSI)", "NRAS gene mutations", "KRAS gene mutations", "BRAF gene mutations", "HRAS gene mutations"] Parameters [] Preparation ["No fasting required.", "Inform lab of any recent transfusions."] Indications ["Guiding targeted therapy in solid malignancies", "Prognosis determination in solid malignancies", "Predicting response to immunotherapies"] Measurement technique Confirm with laboratory Codes LOINC: 95999-1 ICD-10: C80.1 Clinical summary This diagnostic test evaluates microsatellite instability (MSI) status and specific mutations (NRAS, KRAS, BRAF, HRAS) in solid tumor tissue.
TEST-2168 Solid Tumor Panel Genetic Test This test evaluates DNA from a blood sample to identify mutations in over 150 genes associated with solid tumors.	Whole blood (peripheral) or extracted DNA	3–4 weeks (rapid reporting for urgent cases)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations", "Germline mutations", "Genetic variants in 150+ cancer-related genes"] Parameters [] Preparation ["No fasting required.", "Disclose all medications and supplements before sample collection."] Indications ["Guiding targeted therapy", "Prognosis assessment", "Hereditary risk assessment", "Precision oncology protocols"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z12.9 Clinical summary This test evaluates DNA from a blood sample to identify mutations in over 150 genes associated with solid tumors.
TEST-3757 SORL1 Gene Alzheimer’s Disease (Early-Onset, Autosomal Dominant) Genetic Test This test identifies pathogenic variants in the SORL1 gene associated with autosomal dominant early-onset Alzheimer’s disease.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SORL1 gene"] Parameters [{"name": "SORL1 Gene Sequencing", "reference_range": "No pathogenic variants detected"}] Preparation ["Mandatory pre-test genetic counselling session required", "No specific fasting or medication adjustments needed"] Indications ["Suspected autosomal dominant early-onset Alzheimer’s disease", "Family history of early-onset Alzheimer's disease", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21705-3 ICD-10: G30.0 Clinical summary This test identifies pathogenic variants in the SORL1 gene associated with autosomal dominant early-onset Alzheimer’s disease.
TEST-2507 SOS1 Gene Noonan Syndrome Type 4 Genetic Test This genetic test identifies pathogenic variants in the SOS1 gene associated with Noonan syndrome type 4.	Peripheral Whole Blood or Buccal Swab	14 – 21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOS1 gene coding region variants", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation [] Indications ["Diagnostic confirmation of Noonan syndrome type 4", "Genetic counseling", "Cancer surveillance planning"] Measurement technique Confirm with laboratory Codes LOINC: 21735-5 ICD-10: Q87.1 Clinical summary This genetic test identifies pathogenic variants in the SOS1 gene associated with Noonan syndrome type 4.
TEST-362 Soybean GMO Detection Test This test detects the presence of genetically modified soybean DNA in food samples.	Food product sample (raw soybeans, soy flour, soy lecithin, or processed foods containing soy)	5–7 business days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetically modified soybean DNA", "Transgenic elements (CaMV 35S promoter, NOS terminator)"] Parameters [] Preparation [] Indications ["Consumer desire for food transparency", "Dietary choices based on GMO concerns"] Measurement technique Confirm with laboratory Codes LOINC: 10000-1 ICD-10: Z13.8 Clinical summary This test detects the presence of genetically modified soybean DNA in food samples.
TEST-5549 SPAG1 Gene Primary Ciliary Dyskinesia Type 28 Genetic Test This genetic test detects pathogenic variants in the SPAG1 gene associated with primary ciliary dyskinesia type 28.	Peripheral whole blood (EDTA tube) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPAG1 gene", "Single nucleotide variants", "Copy number changes"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications unless instructed by your physician."] Indications ["Suspected primary ciliary dyskinesia type 28", "Family history of PCD", "Chronic respiratory symptoms unresponsive to standard treatment"] Measurement technique Confirm with laboratory Codes LOINC: 56744-3 ICD-10: Q34.8 Clinical summary This genetic test detects pathogenic variants in the SPAG1 gene associated with primary ciliary dyskinesia type 28.
TEST-3144 Sperm DNA Fragmentation (DFI) Test This diagnostic test evaluates the percentage of sperm cells exhibiting DNA damage or fragmentation.	Semen	7 working days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Sperm DNA integrity", "Proportion of fragmented sperm cells"] Parameters [{"name": "DNA Fragmentation Index (DFI)", "reference_range": null}] Preparation ["Abstain from ejaculation for 2 to 5 days before sample collection.", "Avoid excessive heat, alcohol, and smoking 48 hours prior."] Indications ["Evaluation of male infertility", "Assessment before IVF/ICSI", "Investigation of recurrent pregnancy loss", "Diagnosis of recurrent implantation failure"] Measurement technique Confirm with laboratory Codes LOINC: 50696-4 ICD-10: N46.9 Clinical summary This diagnostic test evaluates the percentage of sperm cells exhibiting DNA damage or fragmentation.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories